| Issue Date | Title | Author(s) |
| 2019 | Ambient fine particulate matter inhibits 15-lipoxygenases to promote lung carcinogenesis | Li, Ming-Yue; Liu, Li-Zhong; Li, Wende; Ng, Calvin S. H.; Liu, Yi; Kong, Angel W. Y.; Zhao, Zhili; Wang, Shanshan; Qi, Haolong; Jia, Hao; Yang, Shucai; Du, Jing; Long, Xiang; Ho, Rocky L. K.; Chak, Ernest C. W.; Wan, Innes Y. P.; Mok, Tony S. K.; Underwood, Malcolm J.; Gali, Nirmal Kumar; Ning, Zhi; Chen, George G. |
| 2015 | Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non-small cell lung cancer | Li, Ming-Yue; Yuan, Hui-Ling; Ko, Fanny W. S.; Wu, Bin; Long, Xiang; Du, Jing; Wu, Jun; Ng, Calvin S. H.; Wan, Innes Y. P.; Mok, Tony S. K.; Hui, David S. C.; Underwood, Malcolm J.; Chen, George G. |
| Mar-2020 | Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC | Tan, Wan Ling; Chua, Kevin L. M.; Lin, Chia-Chi; Lee, Victor H. F.; Tho, Lye Mun; Chan, Anthony W.; Ho, Gwo Fuang; Reungwetwattana, Thanyanan; Yang, James C.; Kim, Dong-Wan; Soo, Ross A.; Ahn, Yong Chan; Onishi, Hiroshi; Ahn, Myung-Ju; Mok, Tony S. K.; Tan, Daniel S. W.; Yang, Fan |
| 2015 | Estrogen receptor alpha promotes smoking-carcinogen-induced lung carcinogenesis via cytochrome P450 1B1 | Li, Ming-Yue; Liu, Yi; Liu, Li-Zhong; Kong, Angel W. Y.; Zhao, Zhili; Wu, Bin; Long, Xiang; Wu, Jun; Ng, Calvin S. H.; Wan, Innes Y. P.; Du, Jing; Mok, Tony S. K.; Underwood, Malcolm J.; Chen, George G. |
| 2017 | Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker Analyses | Mok, Tony S. K.; Kim, Sang-We; Wu, Yi-Long; Nakagawa, Kazuhiko; Yang, Jin-Ji; Ahn, Myung-Ju; Wang, Jie; Yang, James Chih-Hsin; Lu, You; Atagi, Shinji; Ponce, Santiago; Shi, Xiaojin; Rukazenkov, Yuri; Haddad, Vincent; Thress, Kenneth S.; Soria, Jean-Charles |
| 2015 | Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation- positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial | Soria, Jean-Charles; Wu, Yi-Long; Nakagawa, Kazuhiko; Kim, Sang-We; Yang, Jin-Ji; Ahn, Myung-Ju; Wang, Jie; Yang, James Chih-Hsin; Lu, You; Atagi, Shinji; Ponce, Santiago; Lee, Dae Ho; Liu, Yunpeng; Yoh, Kiyotaka; Zhou, Jian-Ying; Shi, Xiaojin; Webster, Alan; Jiang, Haiyi; Mok, Tony S. K. |
| 2013 | Thromboxane A2 receptor a promotes tumor growth through an autoregulatory feedback pathway | Huang, Run-Yue; Li, Ming-Yue; Ng, Calvin S. H.; Wan, Innes Y. P.; Kong, Angel W. Y.; Du, Jing; Long, Xiang; Underwood, Malcolm J.; Mok, Tony S. K.; Chen, George G. |
| 2016 | Tumorigenesis of smoking carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is related to its ability to stimulate thromboxane synthase and enhance stemness of non-small cell lung cancer stem cells | Liu, Yi; Yang, Shucai; Li, Ming-Yue; Huang, Runyue; Ng, Calvin S. H.; Wan, Innes Y. P.; Long, Xiang; Wu, Jun; Wu, Bin; Du, Jing; Mok, Tony S. K.; Underwood, Malcolm J.; Chen, George G. |
